hotspot -WSS

hotspot

author：hotspot 2025-10-01 23:39:16 - browse：9

Diversity in clinical trials concept — Adobe

The persistent lack of diversity among participants in clinical trials is a critical issue that is harming both populations that have long been left out of pivotal medical studies and the entire biomedical research enterprise, according to the authors of a report released Tuesday by the National Academies of Sciences, Engineering and Medicine.

Describing the need to move away from trials that focus largely on white men as “urgent,” the report’s authors called for a paradigm shift that gives less power to institutions that fund and conduct clinical research and more to communities under study. The sternly worded report said funding to include and recruit more diverse participants should be a priority that is enforced and said such investments could eventually lead to massive cost savings as the nation’s health disparities are reduced.

“An equitable clinical research enterprise would include trials and studies that match the demographics of the disease burden under study,” the report said. “However, we remain far from achieving this goal.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： CEOs share strategies for surviving biotech slump

entertainment

focus

WSS

New chart reveals military’s vast involvement in Operation Warp Speed

How Brent Saunders' Allergan experiment failed

Pharmacists can make shortage drugs, but at what cost?

It's time to take a new tack for treating Alzheimer's

Eli Lilly expects to double planned employment in Boston center

Senate committee scrutinizes Medicare Advantage brokers

leisure time

hotspot

entertainment

Affirmative action in medical school literally saved lives

Biden White House, tech companies launch new safeguards around emerging AI technology

Malaria cases in Florida and Texas: Here’s what you need to know

Pharmacists can make shortage drugs, but at what cost?

Duchenne breakthrough therapy leaves behind pioneering families

Why health workers in Gaza are injured or die at high rates

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Impact of Dobbs ruling felt at reproductive medicine meeting

Anesthesiologist group: stop taking Ozempic before surgery

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

knowledge

Listen: BridgeBio's big week & Lilly's Alzheimer's data

New chief aims to remake Sanofi Genzyme

NIH confirmation hearing shows politicization of research

CEOs share strategies for surviving biotech slump

STAT Summit: How a Chicago ER doctor tackles gun violence

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

entertainment

focus

leisure time

entertainment